Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 241 of the 241 references it cites were found in a registry or an index.

Epigenetics of colorectal cancer: biomarker and therapeutic potential

Open access
Jung, Gerhard, Hernández-Illán, Eva, Moreira, Leticia, Balaguer, Francesc, Goel, Ajay · 2020 · Nature Reviews Gastroenterology & Hepatology

Abstract

Colorectal cancer (CRC), a leading cause of cancer-related death worldwide, evolves as a result of the stepwise accumulation of a series of genetic and epigenetic alterations in the normal colonic epithelium, leading to the development of colorectal adenomas and invasive adenocarcinomas. Although genetic alterations have a major role in a subset of CRCs, the pathophysiological contribution of epigenetic aberrations in this malignancy has attracted considerable attention. Data from the past couple of decades has unequivocally illustrated that epigenetic marks are important molecular hallmarks of cancer, as they occur very early in disease pathogenesis, involve virtually all key cancer-associated pathways and, most importantly, can be exploited as clinically relevant disease biomarkers for diagnosis, prognostication and prediction of treatment response. In this Review, we summarize the current knowledge on the best-studied epigenetic modifications in CRC, including DNA methylation and histone modifications, as well as the role of non-coding RNAs as epigenetic regulators. We focus on the emerging potential for the bench-to-bedside translation of some of these epigenetic alterations into clinical practice and discuss the burgeoning evidence supporting the potential of emerging epigenetic therapies in CRC as we usher in the era of precision medicine.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41575-019-0230-y

Cites

241 of 241 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

7 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 241 references

Cited by

See all 813

Metadata

Authors
Jung, G., Hernández-Illán, E., Moreira, L., Balaguer, F., & Goel, A.
Affiliations
  • Hospital Clínic de Barcelona (ES)
  • City Of Hope National Medical Center (US)
Corresponding author
  • Balaguer, Francesc
  • Goel, Ajay
Venue
Nature Reviews Gastroenterology & Hepatology
Published
2020-01-03
Volume
17
Issue
2
Pages
111-130
ISSN
  • 1759-5045 (ISSN-L)
  • 1759-5053
OpenAlex
W2997492439
Cited by
813
References
241
Citations by year
2026: 78 · 2025: 108 · 2024: 156 · 2023: 136 · 2022: 137 · 2021: 153 · 2020: 44
FWCI
11.44
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Reviews Gastroenterology & Hepatology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Cancer Institute (R01CA072851, R01CA184792, R01CA202797, U01CA187956, U01CA214254)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
Keywords
colorectal cancer, epigenetics, DNA methylation, histone modifications, non-coding RNA, epigenetic biomarkers, prognostic factors, predictive biomarkers, epigenetic therapy, precision medicine, colorectal adenoma
MeSH terms
Adenocarcinoma, Adenoma, Humans, Prognosis, Biomarkers, Tumor, Colorectal Neoplasms, DNA Methylation, MicroRNAs, Histone Code, Epigenesis, Genetic, Molecular Targeted Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Epigenetics of colorectal cancer: biomarker and therapeutic potential. https://app.cochat.ai/papers/10.1038/s41575-019-0230-y
The paper
Jung, G., Hernández-Illán, E., Moreira, L., Balaguer, F., & Goel, A. (2020). Epigenetics of colorectal cancer: biomarker and therapeutic potential. Nature Reviews Gastroenterology & Hepatology. https://doi.org/10.1038/s41575-019-0230-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.